News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,562 Results
Type
Article (27091)
Company Profile (43)
Press Release (385422)
Multimedia
Podcasts (50)
Webinars (7)
Section
Business (119764)
Career Advice (459)
Deals (17158)
Drug Delivery (76)
Drug Development (48213)
Employer Resources (48)
FDA (12546)
Job Trends (8710)
News (189176)
Policy (20173)
Tag
2025 Best Places to Work (8)
2026 Best Places to Work (12)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (2)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (1821)
Accelerated approval (42)
ADA (32)
Adcomms (12)
Allergies (168)
Alliances (27132)
ALS (164)
Alzheimer's disease (1159)
Antibody-drug conjugate (ADC) (418)
Approvals (13310)
Artificial intelligence (514)
ASCO (211)
Autoimmune disease (286)
Automation (18)
Bankruptcy (154)
Belgium (22)
Best Places to Work (7048)
BIO (29)
Biologics (57)
Biomarkers (1)
BIOSECURE Act (5)
Biosimilars (136)
BioSpace Insights (78)
Biotechnology (27)
Bispecific (49)
Bladder cancer (197)
Brain cancer (58)
Breast cancer (613)
Cancer (4942)
Cardiovascular disease (407)
Career advice (431)
Career pathing (19)
CAR-T (194)
CDC (39)
CDMO (62)
Celiac Disease (6)
Cell-line development (1)
Cell therapy (545)
Cervical cancer (49)
Clinical research (45844)
Collaboration (1349)
Commercialization (56)
Company closure (2)
Compensation (389)
Complete response letters (39)
COVID-19 (1627)
CRISPR (59)
CRO (6)
C-suite (938)
Cystic fibrosis (75)
Data (7463)
Decentralized trials (3)
Denatured (27)
Depression (144)
Dermatology (151)
Diabetes (513)
Diagnostics (4169)
Digital health (55)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (163)
Drug pricing (160)
Drug shortages (24)
Duchenne muscular dystrophy (177)
Earnings (41559)
Editorial (42)
Employer branding (6)
Employer resources (49)
ESMO (414)
Events (58164)
Executive appointments (788)
Eye disease (15)
FDA (16270)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (4)
Friedreich's ataxia (12)
Frontotemporal dementia (20)
Funding (1143)
Gene editing (117)
Generative AI (37)
Gene therapy (415)
GLP-1 (703)
Government (3346)
Grass and pollen (4)
Guidances (283)
Healthcare (12693)
Hematology (147)
HIV (80)
Huntington's disease (42)
Idiopathic pulmonary fibrosis (13)
IgA nephropathy (91)
Immunology and inflammation (112)
Immuno-oncology (81)
Indications (213)
Infectious disease (1850)
Inflammatory bowel disease (165)
Inflation Reduction Act (12)
Influenza (77)
Intellectual property (184)
Interviews (42)
IPO (7193)
IRA (40)
Job creations (1875)
Job search strategy (389)
JPM (19)
Kidney cancer (20)
Kidney disease (123)
Labor market (63)
Layoffs (229)
Leadership (13)
Legal (3917)
Licensing (63)
Liver cancer (82)
Longevity (22)
Lung cancer (787)
Lung diease (16)
Lymphoma (396)
Machine learning (32)
Management (19)
Manufacturing (556)
Marketing (24)
MASH (160)
Medical affairs (6)
Medical device (13756)
Medtech (14071)
Melanoma (81)
Mergers & acquisitions (10749)
Metabolic disorders (1193)
Middle East (2)
mRNA (125)
Multiple sclerosis (166)
NASH (12)
Netherlands (23)
Neurodegenerative disease (283)
Neuropsychiatric disorders (71)
Neuroscience (2382)
Neurotech (1)
NextGen: Class of 2026 (4023)
Non-profit (2986)
Now hiring (54)
Obesity (483)
Opinion (131)
Ovarian cancer (208)
Pain (241)
Pancreatic cancer (274)
Parkinson's disease (262)
Partnered (22)
Patents (368)
Patient advocacy (7)
Patient recruitment (695)
Patient selection (80)
Peanut (55)
People (37246)
Peptides (24)
Pharmaceutical (14)
Pharmacy benefit managers (25)
Phase 1 (13106)
Phase 2 (19844)
Phase 3 (16358)
Pipeline (9152)
Policy (191)
Postmarket research (1682)
Preclinical (4026)
Press Release (18)
Prostate cancer (289)
Psychedelics (41)
Radioligand (2)
Radiopharmaceuticals (268)
Rare diseases (789)
Real estate (2906)
Recruiting (20)
Regenerative medicine (25)
Regulatory (17847)
Reports (31)
Research institute (1734)
Resumes & cover letters (51)
Rett syndrome (34)
RNA editing (13)
RSV (55)
Saudi Arabia (1)
Schizophrenia (168)
Series A (190)
Series B (132)
Series C (1)
Service/supplier (2)
Sickle cell disease (82)
Special edition (11)
Spinal muscular atrophy (113)
Sponsored (19)
Startups (2163)
Stem cells (4)
Stomach cancer (12)
Substance use disorders (16)
Supply chain (86)
Switzerland (16)
Tariffs (41)
Tax incentives (2)
The Weekly (23)
Vaccines (658)
Venture capital (47)
Weight loss (318)
Wet AMD (4)
Women's health (117)
Worklife (5)
Date
Today (63)
Last 7 days (435)
Last 30 days (2105)
Last 365 days (17067)
2026 (15618)
2025 (16644)
2024 (20014)
2023 (22926)
2022 (30874)
2021 (33214)
2020 (32527)
2019 (28889)
2018 (22233)
2017 (19092)
2016 (18351)
2015 (21403)
2014 (16187)
2013 (13404)
2012 (14517)
2011 (14833)
2010 (13378)
Location
Africa (386)
Alabama (36)
Alaska (2)
Arizona (307)
Arkansas (12)
Asia (26801)
Australia (4238)
California (8407)
Canada (2644)
China (1390)
Colorado (463)
Connecticut (440)
Delaware (366)
Europe (52781)
Florida (1402)
Georgia (349)
Hawaii (2)
Idaho (35)
Illinois (954)
India (57)
Indiana (548)
Iowa (16)
Japan (582)
Kansas (109)
Kentucky (37)
Louisiana (48)
Maine (32)
Maryland (1181)
Massachusetts (5567)
Michigan (217)
Minnesota (664)
Mississippi (7)
Missouri (113)
Montana (21)
Nebraska (23)
Nevada (111)
New Hampshire (80)
New Jersey (2918)
New Mexico (11)
New York (2459)
North Carolina (1137)
North Dakota (5)
Northern California (4181)
Ohio (304)
Oklahoma (12)
Oregon (31)
Pennsylvania (1911)
Puerto Rico (19)
Rhode Island (47)
South America (554)
South Carolina (90)
Southern California (3526)
Tennessee (209)
Texas (1655)
United States (32272)
Utah (288)
Virginia (224)
Washington D.C. (53)
Washington State (608)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
412,562 Results for "visby medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Visby Medical Collaborates with Watchmaker Genomics to Enhance Respiratory Pathogen Detection in the At-Home Setting
February 5, 2026
·
3 min read
Press Releases
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
January 9, 2026
·
5 min read
Press Releases
Visby Medical™ Receives FDA Clearance and CLIA Waiver for Point-of-Care Respiratory Health Test
February 26, 2025
·
2 min read
Press Releases
Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual Health
March 28, 2025
·
3 min read
Press Releases
Visby Medical™ Raises up to $65 Million in New Financing Round to Accelerate Launch of Groundbreaking At-Home Sexually Transmitted Infections (STI) Test
June 17, 2025
·
4 min read
Press Releases
The Regulation Of New Medical Tech Is Becoming A Lifelong Process
The Regulation Of New Medical Tech Is Becoming A Lifelong Process
October 26, 2026
·
1 min read
Press Releases
Visby Medical Secures Additional $3.9M from CARB-X to Fight Antibiotic Resistance with PCR-Based Mutation Detection at the POC
January 15, 2025
·
3 min read
Business
Visby Medical Appoints Everett Cunningham to Board of Directors
Visby Medical™, a leading medical diagnostic company, announced Everett Cunningham has been appointed to the company’s Board of Directors.
May 25, 2022
·
2 min read
Biotech Bay
Visby Medical™ Receives FDA Clearance and CLIA Waiver for Second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration for its second generation point of care (POC) test.
March 14, 2023
·
4 min read
FDA
Visby Medical™ Receives FDA Emergency Use Authorization for Respiratory Health Test for use in CLIA waived settings
Visby Medical™ announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.
January 3, 2023
·
3 min read
1 of 41,257
Next